Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Kymera Therapeutics presents clinical data from Phase 1 trial of KT-333 » 07:10
06/14/24
06/14
07:10
06/14/24
07:10
KYMR

Kymera Therapeutics

$34.94 /

+0.375 (+1.08%)

Kymera Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Conference/Events
Kymera Therapeutics participates in a conference call with JPMorgan » 12:55
06/04/24
06/04
12:55
06/04/24
12:55
KYMR

Kymera Therapeutics

$31.96 /

+0.4 (+1.27%)

SMid Cap Biotech Analyst…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Conference/Events
Kymera Therapeutics participates in a conference call with JPMorgan » 11:48
06/04/24
06/04
11:48
06/04/24
11:48
KYMR

Kymera Therapeutics

$32.11 /

+0.55 (+1.74%)

SMid Cap Biotech Analyst…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Kymera presents clinical data from ongoing Phase 1 trial of MDM2 Degrader KT-253 » 07:00
06/02/24
06/02
07:00
06/02/24
07:00
KYMR

Kymera Therapeutics

$32.10 /

-0.035 (-0.11%)

Kymera Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Over a month ago
Hot Stocks
Kymera Therapeutics to present new clinical data for KT-253 at ASCO » 17:11
05/23/24
05/23
17:11
05/23/24
17:11
KYMR

Kymera Therapeutics

$34.26 /

-1.45 (-4.06%)

Kymera Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Kymera Therapeutics presents preclinical data fror KT-621 » 11:21
05/22/24
05/22
11:21
05/22/24
11:21
KYMR

Kymera Therapeutics

$35.37 /

+0.09 (+0.26%)

Kymera Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Kymera Therapeutics to present data from ongoing Phase 1 trial of KT-333 » 10:06
05/14/24
05/14
10:06
05/14/24
10:06
KYMR

Kymera Therapeutics

$38.88 /

+0.47 (+1.22%)

Kymera Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Kymera Therapeutics price target lowered by $1 at Oppenheimer, here's why » 08:30
05/03/24
05/03
08:30
05/03/24
08:30
KYMR

Kymera Therapeutics

$36.28 /

-0.055 (-0.15%)

Oppenheimer analyst Jeff…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Kymera Therapeutics sees cash runway into 1H27 » 07:07
05/02/24
05/02
07:07
05/02/24
07:07
KYMR

Kymera Therapeutics

$36.33 /

+2.74 (+8.16%)

As of March 31, 2024,…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Earnings
Kymera Therapeutics reports Q1 EPS (69c), consensus (73c) » 07:06
05/02/24
05/02
07:06
05/02/24
07:06
KYMR

Kymera Therapeutics

$36.33 /

+2.74 (+8.16%)

Reports Q1 revenue…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
On The Fly
Cisco downgraded, Lucid resumed: Wall Street's top analyst calls » 09:47
04/22/24
04/22
09:47
04/22/24
09:47
WDC

Western Digital

$66.39 /

+0.34 (+0.51%)

, PZZA

Papa John's

$63.41 /

+0.94 (+1.50%)

, AA

Alcoa

$35.75 /

+0.21 (+0.59%)

, NGVT

Ingevity

$46.33 /

+1.825 (+4.10%)

, PPG

PPG

$130.49 /

-0.455 (-0.35%)

, CSCO

Cisco

$48.44 /

+0.11 (+0.23%)

, PLD

Prologis

$103.25 /

-0.24 (-0.23%)

, PACB

PacBio

$1.51 /

-0.045 (-2.90%)

, LCID

Lucid Group

$2.34 /

-0.095 (-3.90%)

, BRBR

BellRing Brands

$54.82 /

+0.89 (+1.65%)

, HUT

Hut 8 Corp.

$8.26 /

+0.22 (+2.74%)

, KYMR

Kymera Therapeutics

$34.90 /

+0.94 (+2.77%)

, SE

Sea Limited

$60.46 /

+5.4 (+9.81%)

The most talked about and…

Initiation
Kymera Therapeutics initiated with bullish view at Oppenheimer, here's why » 07:19
04/22/24
04/22
07:19
04/22/24
07:19
KYMR

Kymera Therapeutics

$33.96 /

-1.19 (-3.39%)

Oppenheimer initiated…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Kymera Therapeutics announces presentation at AACR annual meeting » 07:09
04/08/24
04/08
07:09
04/08/24
07:09
KYMR

Kymera Therapeutics

$36.39 /

+0.18 (+0.50%)

Kymera Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Over a quarter ago
Hot Stocks
Kymera Therapeutics presents preclinical data for STAT6, TYK2 degrader programs » 10:07
03/08/24
03/08
10:07
03/08/24
10:07
KYMR

Kymera Therapeutics

$43.61 /

+0.88 (+2.06%)

Kymera Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Kymera Therapeutics price target raised by $13 at Truist, here's why » 09:59
03/01/24
03/01
09:59
03/01/24
09:59
KYMR

Kymera Therapeutics

$43.10 /

+0.45 (+1.06%)

Truist analyst Srikripa…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Kymera Therapeutics price target raised by $17 at Piper Sandler, here's why » 07:24
02/27/24
02/27
07:24
02/27/24
07:24
KYMR

Kymera Therapeutics

$43.46 /

+1.61 (+3.85%)

Piper Sandler analyst…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Kymera Therapeutics price target raised by $4 at Guggenheim, here's why » 08:42
02/23/24
02/23
08:42
02/23/24
08:42
KYMR

Kymera Therapeutics

$40.53 /

+1.825 (+4.72%)

Guggenheim analyst…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Kymera Therapeutics price target raised by $15 at B. Riley, here's why » 08:28
02/23/24
02/23
08:28
02/23/24
08:28
KYMR

Kymera Therapeutics

$40.53 /

+1.825 (+4.72%)

B. Riley analyst Kalpit…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Kymera Therapeutics price target raised by $4 at Wells Fargo, here's why » 07:35
02/23/24
02/23
07:35
02/23/24
07:35
KYMR

Kymera Therapeutics

$40.53 /

+1.825 (+4.72%)

Wells Fargo raised the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Kymera Therapeutics price target raised by $20 at Stifel, here's why » 07:17
02/23/24
02/23
07:17
02/23/24
07:17
KYMR

Kymera Therapeutics

$40.53 /

+1.825 (+4.72%)

Stifel raised the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Kymera Therapeutics price target raised by $16 at H.C. Wainwright, here's why » 06:09
02/23/24
02/23
06:09
02/23/24
06:09
KYMR

Kymera Therapeutics

$40.53 /

+1.825 (+4.72%)

H.C. Wainwright analyst…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Kymera Therapeutics sees cash runway into 1H27 » 07:05
02/22/24
02/22
07:05
02/22/24
07:05
KYMR

Kymera Therapeutics

$38.70 /

+0.64 (+1.68%)

As of January 9, 2024,…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Earnings
Kymera Therapeutics reports Q4 EPS (25c), consensus (40c) » 07:04
02/22/24
02/22
07:04
02/22/24
07:04
KYMR

Kymera Therapeutics

$38.70 /

+0.64 (+1.68%)

Reports Q4 revenue…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Initiation
Kymera Therapeutics initiated with neutral view at Wolfe Research, here's why » 19:31
02/14/24
02/14
19:31
02/14/24
19:31
KYMR

Kymera Therapeutics

$36.94 /

+1.92 (+5.48%)

Wolfe Research analyst…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Initiation
Kymera Therapeutics initiated with neutral view at Wolfe Research » 16:17
02/14/24
02/14
16:17
02/14/24
16:17
KYMR

Kymera Therapeutics

$36.94 /

+1.92 (+5.48%)

Wolfe Research initiated…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Kymera Therapeutics provides 2024 corporate goals » 09:20
01/09/24
01/09
09:20
01/09/24
09:20
KYMR

Kymera Therapeutics

$26.39 /

-0.81 (-2.98%)

Kymera's corporate…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Kymera Therapeutics sees cash runway into 1H27 » 09:18
01/09/24
01/09
09:18
01/09/24
09:18
KYMR

Kymera Therapeutics

$26.39 /

-0.81 (-2.98%)

"Kymera has taken…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Syndicate
Kymera Therapeutics 2.25M share Spot Secondary priced at $25.25 » 06:08
01/05/24
01/05
06:08
01/05/24
06:08
KYMR

Kymera Therapeutics

$27.24 /

+4.345 (+18.98%)

The deal size was…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Syndicate
Kymera Therapeutics $250M Spot Secondary; re-offered at $25.25 » 16:17
01/04/24
01/04
16:17
01/04/24
16:17
KYMR

Kymera Therapeutics

$27.24 /

+4.345 (+18.98%)

Morgan Stanley, JPMorgan…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Syndicate
Kymera Therapeutics announces $250M common stock offering » 16:06
01/04/24
01/04
16:06
01/04/24
16:06
KYMR

Kymera Therapeutics

$27.11 /

+4.215 (+18.41%)

Kymera Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.